The Imperative of Value-Based Care: Driving Forces and Challenges in the Health Economics and Outcomes Research Service Market
The Health Economics and Outcomes Research (HEOR) Service Market is a critical, high-growth sector, projected to reach an estimated USD 15.5 billion with a significant CAGR of 12.5%, highlighting the essential nature of demonstrating product value in today's cost-conscious healthcare environment. This growth is predominantly fueled by pharmaceutical and biotechnology companies that are increasingly reliant on robust HEOR services to secure successful market access, optimize reimbursement strategies, and establish compelling value propositions for their innovative therapies. The shift toward value-based healthcare—where payment is tied directly to patient outcomes rather than volume of services—amplifies the need for sophisticated economic modeling, comparative effectiveness research, and comprehensive real-world evidence (RWE). Modern HEOR strategies are now integrated earlier in the product lifecycle, moving from traditional post-market validation to proactive, pre-launch evidence generation, which is crucial for…